New Scientist on MSN
Paediatricians’ blood used to make new treatments for RSV and colds
Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...
NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA advisors ...
Add Yahoo as a preferred source to see more of our stories on Google. It's flu season. And COVID season. And RSV season. The Centers for Disease Control and Prevention (CDC) reported that as of last ...
Infections from respiratory syncytial virus (RSV) in children requiring primary care led to significant societal economic costs from outpatient treatment and parental work absences in Europe, ...
Beyfortus is not a vaccine. It’s a monoclonal antibody designed to help protect babies from serious RSV lung infection during ...
Dr. Per Gesteland said he can see a difference in how many infants are being admitted to Primary Children’s Hospital with RSV, respiratory syncytial virus, in the last two years due to a push to ...
Researchers in Sweden conducted a nationwide register-based cohort study to identify risk factors associated with severe outcomes of RSV infection among 2,354,302 children (51.4% boys) born between ...
HOUSTON (KTRK) -- There's concerning news for parents after one Houston-area hospital reports a spike in a potentially life-threatening respiratory disease known as RSV. From the playground to the zoo ...
A pooled analysis of children from three European countries found that immunisation with nirsevimab during the 2024-2025 season effectively prevented respiratory syncytial virus (RSV)-related ...
The Linz Kepler University Hospital reported that last week five children were treated in the intensive care unit with an RSV infection. Infants are particularly at risk from the Respiratory Syncytial ...
New FDA-approved immunizations are crucial for protecting infants from RSV, a leading cause of hospitalization for babies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results